FD274 structure
|
Common Name | FD274 | ||
---|---|---|---|---|
CAS Number | 2641899-38-7 | Molecular Weight | 480.90 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H14ClFN6O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of FD274FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1]. |
Name | FD274 |
---|
Description | FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1]. |
---|---|
Related Catalog | |
Target |
PI3Kα:0.65 nM (IC50) PI3Kβ:1.57 nM (IC50) PI3Kδ:0.65 nM (IC50) PI3Kγ:0.42 nM (IC50) mTOR:2.03 nM (IC50) |
References |
Molecular Formula | C22H14ClFN6O2S |
---|---|
Molecular Weight | 480.90 |